A novel approach to disease prevention and treatment, precision medicine—also referred to as “personalized medicine”—considers variations in people’s genes, environments, and lifestyles. Using biomarkers to separate patients in clinical trials to improve effectiveness and/or safety outcomes increases the chances of clinical success and drug approval. This approach is known as precision medicine.

The significant potential that cell and gene therapies hold in treating a variety of medical conditions for which there are currently no effective treatments is what is driving the surge in demand for these treatments. These conditions mostly include rare genetic disorders, chronic diseases in specialized fields like oncology, and other unusual medical conditions. Pharmaceutical and biotechnology businesses now have a great chance to fund the study, creation, and marketing of cutting-edge cell and gene therapies.

Managing a patient’s health according to their individual characteristics, such as particular genetics, is known as personalized medicine. Predicting the risk of inherited traits like cardiovascular disease is another benefit of identifying genetic information. Additionally, mounting data suggests that a person’s genetic background may influence the choice of effective treatments and prophylactic measures for those with particular genotypes.

Health Technology Insights: Avant Technologies and Ainnova Design Clinical Trial Protocol

For instance, in November 2023, Researchers at Uppsala University developed a tool that makes it possible to measure 21 biomarkers for cardiovascular disease simultaneously with great precision using a simple blood test. The aim is to use this tool to improve the prediction of cardiovascular complications and facilitate more personalized treatment for patients. As a result, precision medicine has the potential to transform the future of Cardiovascular Disease (CVD) healthcare through its use. It enables a doctor to treat heart illnesses on an individual basis, depending on the patient’s specific profile.

Cell and gene therapies are appealing due to their targeted therapeutic effects, positioning them as personalized medicine. In 2022, the FDA endorsed this trend by approving 5 cell and gene therapies as personalized medicines. Consequently, experts in the industry anticipate rapid growth in the field over the coming decade.

The FDA foresees an influx of over 200 investigational new drug applications annually for cell and gene therapies, starting in 2020. By 2025, the regulatory agency anticipates granting approvals for 10 to 20 cell and gene therapy products yearly. According to the Massachusetts Institute of Technology’s New Drug Development Paradigms Initiative, it is projected that by 2030, approximately 500,000 patients in the US will have undergone treatment with cell and gene therapies.

Continuous Renal Replacement Therapy Market

Source: Intent Market Research Analysis

Asia-Pacific appears to be the most promising market in precision medicine due to an increase in cancer and other ailments, as well as increased health awareness among individuals. Precision medicine is a rapidly evolving branch of diagnostics and therapeutics informed by human genetic makeup, lifestyle, and gene expression. Doctors, in Asia-Pacific can use this approach to tailor treatments through the identification of biological pathways causing the disorder.

Moreover, Asian countries have also initiated national genomics programs, building their population genomic databases by sequencing the DNA from healthy individuals. For instance, Thailand government has invested USD 150 million in the Genomics Thailand Initiative, a collaboration between academic institutions and the Ministry of Health, to sequence the genomes of 50,000 Thai people by 2024. Such attempts to create local genetic data banks aid in serving as a reference for genetic normalcy that is more relevant to local/Asian people than databases obtained from Western populations.

Health Technology Insights: HealthTrackRx Welcomes Dana Simonds as Chief Compliance Officer

Similarly, the Chinese Academy of Sciences has issued invitations to apply for funding for projects under the China Precision Medicine Initiative, a USD 9.2 billion, 15-year project announced during the National People’s Congress sessions. All such government initiatives in precision medicine are providing potential growth opportunities in the Asia-Pacific and hence propelling the market growth.

The precision medicine market demonstrates intense competition, with key players in the market, including AbbVie, AstraZeneca, Bristol Myers Squibb, and Eli Lilly and Company. Major market players have actively pursued strategic alliances, partnerships, mergers and acquisitions, and geographical expansion endeavours to fortify their market positions. The report incorporates both qualitative and quantitative analyses of these vendors, offering clients a comprehensive understanding of the broader business landscape and the ability to assess the strengths and weaknesses of key market players.

TRENDING REPORTS

Health Technology Insights: HealthScape Advisors Medicare Advantage market growth continues despite headwinds

To participate in our interviews, please write to our HealthTech Media Room at sudipto@intentamplify.com

About  Intent Market Research™

Intent Market Research (IMR) is a market research firm dedicated to providing unique, data-driven insights that support sustainable and inclusive business growth. We specialize in comprehensive market research reports and consulting services across diverse industries including chemicals, healthcare, automotive, energy, packaging, and semiconductor & electronics.

Our approach centers on delivering transformative market intelligence through syndicated reports, custom research, and strategic consulting services. We work closely with clients to develop tailored solutions that address unique business challenges, offering quantifiable market insights and forward-looking strategies. Our team of expert analysts and consultants combines cutting-edge competencies with a robust research methodology to help businesses explore new markets, develop innovative products, and uncover growth opportunities.

At IMR, we are committed to ethical standards and compliance, conducting research with transparency and integrity. We prioritize data privacy, maintain strict confidentiality, and adhere to industry regulations. Our goal is to empower businesses with comprehensive, fact-based insights that drive sustainable advantages and meaningful organizational change.

To find out more, visit Intent Market Research™ or follow us on LinkedIn. 

Contact:
Mr. Jay Kumar
Intent Market Research

1846 E Innovation Park DR Site
100 ORO Valley
AZ 85755

USA: +1 463-583-2713
Email: sales@intentmarketsearch.com